ROCKVILLE, Md., Jan. 26 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. announced today that its presentation at the Wachovia Securities Small and Mid-Cap Healthcare Conference will be webcast and may be accessed at http://www.hgsi.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )
A member of Human Genome Sciences’ senior management team will present an overview of the company on Tuesday, January 30, 2007, at 10:45 am Eastern Time.
Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.
The mission of Human Genome Sciences is to discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody drugs.
HGS and Human Genome Sciences are registered trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the company’s web site at http://www.hgsi.com.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comHuman Genome Sciences, Inc.
CONTACT: Jerry Parrott, Vice President, Corporate Communications,+1-301-315-2777, or Kate de Santis, Director, Investor Relations,+1-301-251-6003, both of Human Genome Sciences, Inc.
Web site: http://www.hgsi.com/
Company News On-Call: http://www.prnewswire.com/comp/121115.html/
